Detalhe da pesquisa
1.
Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol).
BMC Cancer
; 23(1): 344, 2023 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060055
2.
T1 Mapping From MPRAGE Acquisitions: Application to the Measurement of the Concentration of Nanoparticles in Tumors for Theranostic Use.
J Magn Reson Imaging
; 58(1): 313-323, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315197
3.
A post-conflict vaccination campaign, Central African Republic.
Bull World Health Organ
; 96(8): 540-547, 2018 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30104794
4.
In vivo pink-beam imaging and fast alignment procedure for rat brain tumor radiation therapy.
J Synchrotron Radiat
; 23(1): 339-43, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26698083
5.
Identification of AREG and PLK1 pathway modulation as a potential key of the response of intracranial 9L tumor to microbeam radiation therapy.
Int J Cancer
; 136(11): 2705-16, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25382544
6.
Nebulized gadolinium-based nanoparticles: a theranostic approach for lung tumor imaging and radiosensitization.
Small
; 11(2): 215-21, 2015 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25201285
7.
Multiparametric MRI as an early biomarker of individual therapy effects during concomitant treatment of brain tumours.
NMR Biomed
; 28(9): 1163-73, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26224287
8.
The In Vivo Radiosensitizing Effect of Gold Nanoparticles Based MRI Contrast Agents.
Small
; 2014 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24677791
9.
The in vivo radiosensitizing effect of gold nanoparticles based MRI contrast agents.
Small
; 10(6): 1116-24, 2014 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24659273
10.
Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.
Tumour Biol
; 35(7): 6221-33, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24633919
11.
A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications.
Chemistry
; 19(19): 6122-36, 2013 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23512788
12.
Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: effect of an antiangiogenic treatment on a gliosarcoma model.
Radiology
; 265(3): 743-52, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22996750
13.
Increase of lifespan for glioma-bearing rats by using minibeam radiation therapy.
J Synchrotron Radiat
; 19(Pt 1): 60-5, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22186645
14.
Meloxicam can Potentiate the Therapeutic Effects of Synchrotron Microbeam Radiation Therapy on High-Grade Glioma Bearing Rats.
Radiat Res
; 197(6): 655-661, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35245385
15.
Non-conventional Ultra-High Dose Rate (FLASH) Microbeam Radiotherapy Provides Superior Normal Tissue Sparing in Rat Lung Compared to Non-conventional Ultra-High Dose Rate (FLASH) Radiotherapy.
Cureus
; 13(11): e19317, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35223216
16.
3D Spatial Distribution of Nanoparticles in Mice Brain Metastases by X-ray Phase-Contrast Tomography.
Front Oncol
; 11: 554668, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34113554
17.
Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial).
Radiother Oncol
; 160: 159-165, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961915
18.
Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media.
Radiology
; 257(2): 342-52, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20829544
19.
Advanced contrast modalities for X-ray radiology: Phase-contrast and dark-field imaging using a grating interferometer.
Z Med Phys
; 20(1): 7-16, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211422
20.
Targeting brain metastases with ultrasmall theranostic nanoparticles, a first-in-human trial from an MRI perspective.
Sci Adv
; 6(29): eaay5279, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32832613